Holders

EYEPOINT PHARMACEUTICALS INC

Q4 2024 13F holders

CUSIP
30233G209
Type
Equity
Class
COM NEW
Total Reported Value ($000, excl. options)
Manager Report date Value ($000) Shares Option type